Analgesic efficacy of caudal dexamethasone combined with ropivacaine in day case herniotomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201505001138361

Enrollment

Registered

2015-05-09

Start date

2015-05-09

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Paediatrics Hernia, Herniotomy

Interventions

Ropivacaine and Dexamethasone

Ropivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children aged between one and six years in the American Society of Anesthesiologists physical class I and II who are scheduled to undergo unilateral herniotomy exclusively as day case procedures.

Exclusion criteria

Exclusion criteria: ¿ Parent or guardians¿ refusal. ¿ Patients with known allergy to ropivacaine or dexamethasone. ¿ Patients on steroid therapy. ¿ Patients with sacral abnormalities. ¿ Patients with spina bifida. ¿ Patients with infection at the injection site. ¿ Patients with coagulopathy. ¿ Use of analgesic medication or drugs that modify perception of pain. ¿ Previous/Recurrent Inguinal Hernia

Design outcomes

Secondary

Measure	Time frame
Parents or gaurdians satisfaction	—

Primary

Measure	Time frame
Pain	—

Countries

Nigeria

Contacts

Public ContactAdeolu Adeyeye

Medical Doctor/Ondo State Trauma and Surgical Center, Ondo.

contact_deo@yahoo.com07030393246

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026